| 2022-11-29 | Sale | Kiniksa Pharmaceuticals, Ltd. KNSA | director | 21,959 0.0318% | $16.15 | $354,638 | -6.53% | |
| 2019-10-03 | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 9,142 0.0046% | $8.75 | $79,993 | -8.03% | ||
| 2018-06-21 | Sale | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 100,000 0.0837% | $24.05 | $2.4M | -32.09% | |
| 2018-03-19 | Sale | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 200,000 0.2091% | $18.48 | $3.69M | +9.71% | |
| 2018-03-14 | Sale | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 200,000 0.2224% | $15.97 | $3.19M | +34.91% | |
| 2015-03-02 | Sale | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 20,000 0.0667% | $13.07 | $261,454 | +95.57% | |
| 2014-06-25 | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 20,000 0.0832% | $11.75 | $235,000 | -19.42% | ||
| 2013-11-20 | Heron Therapeutics, Inc. HRTX | Chief Executive Officer | 2M 0.5755% | $0.40 | $800,000 | +14.48% |